Stephen Walsh
27PUBLICATIONS
176CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (27)
Sort by Publication Date:
|Apr 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).Stephen Walsh, William O Hahn, Wilton B Williams
|Nov 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.Urjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener
|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.K Rachael Parks, Zoe Moodie, Mary A Allen
|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).Sharon A Riddler, Zoe Moodie, Jesse Clark
|Apr 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.Leigh H Fisher, Erica Lazarus, Chenchen Yu
|Jun 24, 2024
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.Stephen R Walsh, Cynthia L Gay, Shelly T Karuna
Pageof 5
Frequent Collaborators
5 joint publications
David Montefiori
4 joint publications
Yehuda Z Cohen
4 joint publications
Zoe Moodie
4 joint publications
Georgia D Tomaras
4 joint publications
Kelly Seaton
3 joint publications
Janneke Van't Hooft
3 joint publications
Andreas M Schmitt
3 joint publications
Guiseppe Pantaleo
3 joint publications
Mary Allen
3 joint publications
Maurine D Miner
